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Abstract	
Coronary	artery	disease	remains	the	leading	cause	of	death	in	the	developed	world.	Over	recent	years,	research	has	
been	focused	on	the	development	of	diagnostic	intravascular	imaging	techniques	that	enable	assessment	of	plaque	
composition	and	morphology,	and	allow	identification	of	vulnerable,	high-risk	lesions.	Nevertheless	recent	studies	of	
coronary	atherosclerosis	have	shown	that	invasive	modalities	have	a	limited	accuracy	in	detecting	lesions	that	will	
progress	and	cause	events,	whilst	histology-based	studies	also	highlighted	the	limitations	of	invasive	imaging	in	
assessing	plaque	characteristics.	To	overcome	these	drawbacks,	multimodality	imaging	has	been	proposed.	Although	
it	is	apparent	that	coronary	imaging	with	two	or	three	imaging	modalities	is	time	consuming	and	is	associated	with	a	
risk	of	complications,	evidence	from	small	clinical	studies	demonstrated	that	it	provides	incremental	information	
about	plaque	pathology	and	biology	and	underscored	the	need	to	develop	dual-probe	hybrid	imaging	catheters	that	
would	enable	complete	and	comprehensive	assessment	of	plaque	morphology.	This	paper	reviews	the	current	
clinical	evidence	that	supports	the	use	of	multimodality	intravascular	imaging	in	the	study	of	atherosclerosis,	
summarizes	the	key	findings	of	the	first	invasive	imaging	studies	that	utilize	hybrid	dual-probe	catheters,	and	
discusses	the	limitations	of	combined	intravascular	imaging	that	restrict	its	broad	application	in	both	the	clinical	and	
research	arena.	
	
Keywords:	multimodality	imaging	•	atherosclerosis	•	vulnerable	plaque	
	
	
	 2	
Introduction	
	
Coronary	angiography	has	long	been	considered	the	gold	standard	imaging	modality	for	the	evaluation	of	coronary	
artery	disease.	Coronary	angiography	however,	has	significant	limitations	in	the	assessment	of	lesion	pathology	and	
biology.	Whilst	enabling	two	dimensional	(2D)	visualization	of	luminal	silhouette,	it	does	not	permit	the	evaluation	of	
the	plaque	characteristics,	which	appear	to	determine	its	natural	course	and	vulnerability.	
	
The	in	vivo	assessment	of	plaque	characteristics	first	became	feasible	in	the	beginning	of	nineties	with	the	introduction	
of	 intravascular	ultrasound	 (IVUS)	 imaging.	The	application	of	 this	 technique	 in	 the	clinical	 setting	heightened	our	
appreciation	of	the	limitations	of	coronary	angiography	in	assessing	the	severity	of	a	lesion	and	plaque	morphology,	
and	 emphasized	 the	 need	 to	 develop	 alternative	 imaging	modalities	 for	 studying	 coronary	 plaque	 characteristics.	
Several	 intravascular	 imaging	 techniques	 have	 been	 developed	 over	 the	 past	 few	 years	 that	 have	 enhanced	 our	
understanding	of	atherosclerotic	evolution.	Some	of	these	modalities	have	been	validated	and	are	currently	part	of	
daily	clinical	practice	[e.g.	optical	coherence	tomography	(OCT),	and	near	infrared	spectroscopy	(NIRS)],	whilst	others	
remain	in	the	development	phase	and	under	pre-clinical	evaluation	(i.e.	Raman	spectroscopy,	photoacoustic	imaging,	
intravascular	magnetic	 resonance	 imaging,	near	 infrared	 fluorescence	 imaging,	and	 fluorescence	 lifetime	 imaging).	
Histology-based	and	clinical	studies	have	provided	robust	evidence	about	the	clinical	and	research	potential	of	the	
clinically	applicable	modalities	but	also	revealed	their	limitations	in	the	study	of	atherosclerosis	(see	Supplementary	
data	online,	Supplementary	Data).	To	overcome	 the	 inherent	drawbacks	of	 the	existing	 techniques,	multimodality	
intravascular	imaging	was	proposed	in	order	to	synergize	their	strengths	for	better	assessment	of	plaque	morphology	
and	 vulnerability	 (Figure	 1).	 Today,	 several	 dualprobe	 catheters	 have	 been	 developed	 that	 enable	 combined	
intravascular	imaging	of	plaque	pathobiology.1	
	
In	 this	 review	 article,	 we	 present	 the	 evidence	 from	 clinical	 studies	 that	 supports	 the	 value	 of	 multimodality	
intravascular	imaging	in	the	study	of	atherosclerosis	(see	Supplementary	data	online,	Table	S1),	summarize	the	key	
findings	of	the	first	human	studies	that	evaluated	the	use	of	dual-probe	catheters	to	assess	plaque	morphology,	and	
discuss	the	future	perspectives	of	multimodality	imaging.	
	
	
Multimodality	imaging	in	the	study	of	atherosclerosis:	feasibility	and	current	evidence	
	
Intravascular	ultrasound	and	optical	coherence	tomographic	imaging	
Sawada	et	al.	were	the	first	to	suggest	the	combined	use	of	RF-IVUS	and	OCT	to	assess	plaque	pathology,	advocating	
that	imaging	with	two	imaging	modalities	with	complementary	strengths	would	enable	more	reliable	evaluation	of	
plaque	morphology.2	One	hundred	and	six	coronary	plaques	in	56	patients	who	underwent	coronary	angiography	for	
stable	angina	were	included	in	the	analysis.	The	authors	found	significant	discrepancies	between	RF-IVUS	and	OCT	and	
concluded	that	both	modalities	are	necessary	for	an	accurate	assessment	of	the	phenotype	of	plaque.	In	particular,	
the	moderate	resolution	of	RF-IVUS	did	not	permit	accurate	differentiation	between	TCFA	and	FA,	whereas	OCT	often	
failed	to	characterize	the	superficial	necrotic	core	component	in	vessels	with	a	larger	lumen,	likely	due	to	the	limited	
penetration	of	the	optical	signal.	These	results	were	confirmed	by	ex	vivo	histology-based	studies	which	showed	that	
the	combination	of	both	RF-IVUS	and	OCT	permits	more	accurate	identification	of	high-risk	plaques.3,4	
	
In	 another	 study,	 Gonzalo	 et	 al.	 focused	 on	 bifurcation	 lesions	 and	 used	 the	 origin	 of	 side	 branches	 as	matching	
anatomical	landmarks	between	IVUS	and	OCT.5	The	authors	developed	a	methodology	that	takes	into	consideration	
plaque	characteristics	identified	in	both	IVUS	and	OCT	images	to	define	the	phenotype	of	the	plaque	and	found	that	
high-risk	plaques	with	a	thin	fibrous	cap	are	seen	more	often	at	the	proximal	rim	of	the	bifurcation.	The	same	research	
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group	 implemented	 serial	 combined	 IVUS-OCT	 imaging	 in	 24	 patients	 to	 study	 bifurcation	 lesions	 and	 found	 no	
difference	 in	 the	 fibrous	 cap	 thickness	 and	 necrotic	 core	 after	 6	 months	 follow-up.6	 These	 findings	 contradict	 a	
previous	RF-IVUS-based	study,	which	showed	that	the	phenotype	of	the	plaque	rapidly	changes	with	time	with	high-
risks	plaques	regressing	to	stable	forms	and	stable	lesions	progressing	to	high	risk	phenotypes.7	
	
Recently,	Tian	et	al.	evaluated	plaque	characteristics	using	combined	IVUS-OCT	imaging	in	lesions	with	various	degrees	
of	severity	and	found	that	lesions	with	significant	luminal	stenoses	(>70%	diameter	stenosis)	had	an	increased	plaque	
burden,	were	more	often	TCFAs,	and	exhibited	neo-vessels	and	cholesterol	crystals	more	frequently	than	the	lesions	
with	a	mild	 (30–49%)	or	moderate	stenosis	 (50–69%).8	These	results	 indicate	 that	severely	stenotic	 lesions	have	a	
vulnerable	 phenotype	 and	 are	 thus	 more	 likely	 to	 cause	 cardiovascular	 events	 compared	 to	 those	 with	 mild	 or	
moderate	severity,	contradicting	the	findings	of	angiographic-based	studies,	conducted	in	1980s,	that	suggested	that	
myocardial	infarction	is	more	likely	caused	by	non-flow	limiting	lesions.9	
	
In	another	study,	the	same	research	group	used	IVUS	and	OCT	to	 investigate	plaque	characteristics	of	 lesions	that	
rupture	and	cause	cardiovascular	events.10	One	hundred	and	twenty	six	plaques	with	a	TCFA	phenotype	(49	ruptured	
plaques	that	caused	an	event,	19	ruptured	plaques	that	did	not	cause	an	event,	and	58	non-ruptured	plaques)	in	82	
patients	 were	 included	 in	 the	 analysis.	 There	were	 no	 differences	 between	 the	 three	 groups	 in	 the	 incidence	 of	
macrophages,	neo-vessels,	calcifications,	and	cholesterols	crystals.	Ruptured	plaques	more	often	had	thrombus,	and	
a	 thinner	 fibrous	 cap	 compared	 to	 the	non-ruptured	TCFA.	Ruptured	plaques	 that	 caused	an	event	had	a	 smaller	
luminal	area	and	increased	plaque	burden	compared	to	the	plaques	that	ruptured	and	did	not	cause	an	event.	OCT-
derived	plaque	characteristics	and	in	particular	cap	thickness	had	higher	predictive	value	for	ruptured	plaques,	whilst	
the	plaque	burden	assessed	by	IVUS	had	higher	predictability	to	ruptured	plaques	which	caused	events	(Figure	2).	The	
findings	of	this	study	demonstrated	the	value	of	combined	imaging	in	identifying	lesions	that	are	prone	to	progress,	
rupture	and	cause	cardiovascular	events,	and	questioned	the	argument	that	intravascular	imaging	cannot	differentiate	
lesions	that	will	silently	rupture	from	those	that	will	cause	an	event.	
	
Moreover,	 a	 recent	 report	 used	 combined	 IVUS-OCT	 imaging	 to	 compare	 plaque	 characteristics	 in	 133	 patients	
admitted	with	an	ACS	because	of	plaque	rupture	and	plaque	erosion.11	Ruptured	plaques	had	increased	plaque	burden	
and	necrotic	core	component,	exhibited	more	often	positive	remodelling,	had	a	TCFA	phenotype	and	were	located	
either	proximally	or	distally	to	the	minimum	lumen	area	site.	On	the	other	hand,	lesions	with	plaque	erosion	had	more	
often	negative	remodelling,	exhibited	modest	plaque	burden,	were	fibrotic-rich	and	half	of	the	them	were	located	
proximally	to	the	minimum	lumen	area	site,	a	quarter	of	them	in	the	minimum	lumen	area	site	and	another	quarter	
distally	to	the	minimum	lumen	area	site.	These	findings	indicate	the	different	patho-biological	mechanisms	involved	
in	formation	and	destabilization	of	plaques	that	will	erode	from	those	that	determine	the	natural	evolution	of	plaques	
that	will	rupture	and	cause	cardiovascular	events.	
	
Three	 prospective	 studies	 used	 combined	 IVUS	 and	 OCT	 imaging	 to	 examine	 the	 effect	 of	 statin	 therapy	 on	 the	
compositional	characteristics	of	the	plaque,	with	the	Integrated	Biomarkers	Imaging	Study	4	(IBIS	4),	being	the	largest	
study	of	its	kind	(see	Supplementary	data	online,	Table	S1).	IBIS	4	used	combined	3-vessel	RF-IVUS	and	OCT	imaging	
to	assess	plaque	morphology	and	characteristics	 in	patients	with	a	ST-elevation	myocardial	 infarction	 (STEMI).12	 It	
included	103	patients	treated	with	high	intensity	rosuvastatin	40	mg	od	who	had	serial	 imaging	at	baseline	and	13	
months	 follow-up.	 The	 results	 from	 the	 IVUS	 analysis–the	 OCT	 analysis	 has	 not	 been	 presented	 yet–showed	 a	
regression	in	the	percent	atheroma	volume	at	13	months	follow-up	(–0.9%,	P=0.007).13	OCT	and	RF-IVUS	imaging	was	
feasible	in	the	vast	majority	of	the	cases	at	both	baseline	(OCT:	89.9%,	RF-IVUS:	85.7%)	and	follow-up	(OCT:	86.6%,	
RF-IVUS:	 84.8%).	 The	 complications	 rates	 were	 low:	 1.9%	 at	 baseline	 and	 1.1%	 at	 follow-up.	 When	 the	 authors	
compared	outcomes	between	patients	who	had	PCI	with	and	without	multimodality	intravascular	imaging	they	found	
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no	 difference	 in	 the	 incidence	 of	 acute	 kidney	 injury	 (1.0%	 vs.	 1.9%,	 P=	 0.72),	 or	 the	 incidence	 of	major	 adverse	
cardiovascular	events	after	2	years	follow-up	(16.7%	vs.	13.3%,	P	=	0.39).	Considering	that	the	advancement	of	the	
IVUS	or	OCT	catheters	could	cause	endothelial	injury,	the	authors	compared	the	incidence	of	revascularization	in	the	
non-infracted	arteries	and	found	no	statistical	differences	between	patients	who	had	intravascular	imaging	compared	
to	 those	who	had	not	 (9.0%	vs.	4.8%,	P=	0.20).	These	 findings	 suggest	 that	multimodality	 intravascular	 imaging	 is	
feasible	and	safe,	even	in	high-risk	patients	treated	for	STEMI.	
	
Intravascular	ultrasound–near	infrared	spectroscopic	imaging	
The	first	IVUS-NIRS	studies	focused	on	the	comparison	of	RF-IVUS	and	NIRS	in	assessing	the	composition	of	the	plaque	
and	demonstrated	a	weak	correlation	in	the	estimation	of	the	two	modalities	with	regards	to	the	lipid	burden.14,15	
Similar	were	the	findings	of	a	small	scale	study	that	compared	NIRS	and	OCT.16	These	discrepancies	between	different	
imaging	 modalities	 are	 due	 to	 the	 limitations	 of	 each	 modality	 and	 underscore	 the	 potential	 additive	 value	 of	
multimodality	imaging	for	more	accurate	plaque	characterization.	This	hypothesis	was	confirmed	by	histology-based	
studies	which	showed	that	combined	IVUS-NIRS	imaging	allows	more	accurate	identification	of	high-risk,	vulnerable	
plaques.17,18	
	
The	Reduction	in	Yellow	Plaque	by	Intensive	Lipid	Lowering	Therapy	(YELLOW)	was	the	first	study	that	used	combined	
IVUS	and	NIRS	imaging	to	assess	the	effect	of	aggressive	lipid	lowering	treatment	in	flow	limiting	lesions.19	In	this	study,	
IVUS	 and	 NIRS	 imaging	 was	 performed	 at	 baseline	 and	 at	 7	 weeks	 follow-up	 in	 lesions	 with	 a	 fractional	 flow	
reserve<0.80	 in	 87	 patients	 who	 were	 randomized	 to	 aggressive	 or	 standard	 of	 care	 lipid	 therapy.	 Anatomical	
landmarks	and	angiographic	images	were	used	to	co-register	the	IVUS	and	the	NIRS	data	acquired	at	the	two	time	
points.Within	2	months	there	was	a	24%	reduction	in	the	lipid	component	and	an	increase	in	the	elastic	membrane	
area	by	9%	in	the	intensive	treatment	group,	whilst	in	the	standard	of	care	group	the	change	in	the	lipid	component	
was	increased	by	5.4%	and	the	external	elastic	membrane	by	3%.	Concerns	were	raised	that	these	ambiguous	results	
(i.e.	the	excessive	reduction	in	lipid	component,	which	was	much	greater	than	had	been	reported	in	other	studies,	and	
the	increase	in	the	outer	vessel	wall	area)	could	have	been	caused	by	inaccurate	co-registration	of	the	two	imaging	
modalities	at	baseline	and	follow-up,	and	highlighted	the	need	to	develop	hybrid	dual-probe	catheters	that	would	
allow	accurate	co-registration	of	the	acquired	data.20	
	
Combined	RF-IVUS	and	NIRS	imaging	was	also	used	to	assess	the	effect	of	aggressive	lipid	lowering	treatment	with	
rosuvastatin	 on	 the	 plaque	 burden	 and	 composition	 in	 the	 Integrated	 Biomarkers	 Imaging	 Study	 3	 (IBIS	 3)	which	
included	164	patients	who	underwent	coronary	angiography	for	clinical	purposes	and	had	serial	single	vessel	RF-IVUS	
imaging	at	baseline	and	6	or	12	months	follow-up.21	One	hundred	three	of	these	patients	also	had	serial	NIRS	imaging.	
In	contrast	to	the	YELLOW	study,	IBIS	failed	to	demonstrate	a	treatment	effect	on	the	lipid	component	and	there	was	
an	 increase	 in	 the	 percentage	 atheroma	 volume	 at	 follow-up	 (see	 Supplementary	 data	 online,	 Table	 S1).	 Further	
information	about	the	implications	of	lipid	lowering	treatment	on	plaque	characteristics	are	expected	to	be	provided	
by	the	Reduction	in	Coronary	Yellow	Plaque,	Lipids	and	Vascular	Inflammation	by	Aggressive	Lipid	Lowering	(YELLOW	
II)	study	which	is	actively	enrolling	patients	with	lipid	rich	lesions	that	will	have	serial	IVUS-NIRS	and	OCT	imaging	at	
baseline	and	8–12	weeks	follow-up	(NCT01837823).	
	
	
	 	
	 5	
Hybrid	intravascular	imaging:	first	human	studies	of	dual-probe	catheters	
	
The	miniaturization	of	medical	devices	and	advances	in	imaging	processing	has	enabled	the	construction	of	dual-probe	
catheters	which	provide	comprehensive	visualization	and	complete	assessment	of	plaque	pathophysiology.	Several	
prototypes	 are	 currently	 under	 development	 including	 the	 combined	 IVUS-OCT,	 NIRS-OCT,	 IVUS-near	 infrared	
fluorescence	(NIRF),	 IVUS-photoacoustics	and	 IVUS-fluorescence	 lifetime	 imaging	and	have	recently	been	tested	 in	
histology	studies	and	animal	studies	providing	promising	results	(Figure	3).	However	technical	limitations	(i.e.	relatively	
large	catheters,	poor	imaging	quality,	increased	time	for	data	acquisition,	need	for	blood	removal)	have	not	allowed	
their	application	in	the	clinical	arena	yet.1	
	
Today	 two	 catheters,	 the	 combined	 NIRS-IVUS	 and	 the	 OCT-NIRF	 have	 been	 used	 in	 the	 clinical	 setting	 (see	
Supplementary	data	online,	Table	S2).	
	
Hybrid	near	infrared	spectroscopy-intravascular	ultrasound	catheter	
The	NIRS-IVUS	catheter	(TVC,	InfraReDx,	Inc.,	Burlington,	Massachusetts)	 incorporates	a	rotational	IVUS	transducer	
with	a	NIRS	probe	on	a	single	3.2Fr	catheter	and	provides	cross	sectional	images	of	the	coronary	arteries	where	the	
IVUS	and	NIRS	information	is	co-registered	allowing	assessment	of	the	lumen	and	outer	vessel	wall	morphology,	and	
evaluation	 of	 plaque	 distribution	 and	 composition.	 The	 catheter	 is	 commercially	 available	 and	 has	 received	 FDA	
approval	 for	 the	 study	 of	 the	 composition	 of	 the	 plaque.	 Several	 reports	 used	 this	 modality	 to	 assess	 plaque	
characteristics	 and	 vulnerability.	 Roleder	 et	 al.	 used	 OCT	 as	 gold	 standard	 to	 assess	 the	 efficacy	 of	 NIRS-IVUS	 in	
evaluating	plaque	phenotype	and	demonstrated	that	combined	NIRS-IVUS	imaging	allows	detection	of	OCT-derived	
TCFA	with	a	high	sensitivity	and	specificity	(100%	and	91%,	respectively).22	A	limitation	of	this	analysis	however,	was	
the	fact	that	the	authors	used	OCT	as	a	reference	instead	of	using	the	information	by	all	the	three	imaging	modalities	
to	more	accurately	characterize	plaque	morphology.20	
	
Madder	et	al.	used	NIRS-IVUS	to	assess	plaque	characteristics	in	20	patients	admitted	with	STEMI	and	showed	that	
culprit	lesions	have	specific	morphological	characteristics	i.e.	an	increased	plaque	burden	and	lipid	component	that	
allow	their	differentiation	from	the	non-culprit	lesions	with	a	high	accuracy	[area	under	the	curve	(AUC):	0.90].23	A	
larger	 scale,	 two	 centre	 study	 including	 75	 patients	 admitted	 with	 a	 STEMI	 has	 confirmed	 the	 above	 findings	
demonstrating	that	the	maximum	lipid	plaque	burden	index	in	a	4	mm	segment	was	able	to	differentiate	culprit	from	
the	non-culprit	lesions	with	a	sensitivity	and	specificity	of	64%	and	85%,	respectively.24	The	same	research	group	has	
reported	 similar	 findings	 in	 patients	 admitted	 with	 non-STEMI	 and	 unstable	 angina:	 NIRS-IVUS	 imaging	 enabled	
identification	 of	 culprit	 lesions	 with	 high	 accuracy	 in	 both	 studied	 groups	 (AUC:	 0.87	 and	 0.79,	 respectively).25	
Nevertheless,	there	is	no	prospective	data	today	about	the	predictive	value	of	the	combined	NIRS-IVUS	imaging	to	
detect	high-risk	prone	to	rupture	plaques.	To	answer	this	questions	two	studies,	the	Prospective	Natural	History	Study	
Using	Multimodality	Imaging	in	Patients	With	Acute	Coronary	Syndromes	(PROSPECT	II,	NCT02171065)	and	the	Lipid	
Rich	Plaque	(NCT02033694),	have	recently	commenced	and	are	anticipated	to	provide	further	insights	about	the	value	
of	hybrid-intravascular	imaging	in	vulnerable	plaque	detection.	
	
Combined	IVUS-NIRS-OCT	imaging	has	also	been	used	to	evaluate	the	effect	of	sex	on	plaque	morphology	in	patients	
with	stable	angina.26	In	the	study	of	Bharadwaj	et	al.,	128	patients	(95	men	and	33	women)	with	stable	angina	had	
combined	IVUS-NIRS	and	OCT	imaging	of	the	culprit	lesions.	There	were	no	significant	differences	between	groups	in	
the	thickness	of	the	fibrous	cap,	the	incidence	of	TCFA,	macrophage	accumulation,	microvessels	and	the	calcific	and	
lipid	burden–assessed	by	NIRS.	Male	patients	had	an	increased	plaque	burden	compared	to	females	but	this	difference	
was	not	statistically	significant	when	patient	clinical	characteristics	were	taken	into	account.	
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Hybrid	optical	coherence	tomography	near	infrared	fluorescence	imaging	catheter	
NIRF	 involves	 the	 injection	 of	 activatablemarkers	 that	 have	 the	 ability	 to	 bind	molecules	 associated	 with	 plaque	
vulnerability	and	fluoresce	when	they	are	irradiated	with	near	infrared	light.	Combined	OCT-NIRF	imaging	provides	
unique	opportunities	for	studying	plaque	pathophysiology	as	OCT	is	able	to	assess	luminal	dimensions	and	plaque	
morphology	 while	 NIRF–depending	 on	 the	 activatable	 marker	 that	 is	 used	 for	 imaging–appears	 able	 to	 detect	
molecules	associated	with	increased	inflammation	such	as	matrix	metalloproteinases	or	cathepsins.27	Today	two	OCT-
NIRF	catheters	are	available	that	incorporate	an	OCT	probe	and	a	NIRF	transducer	into	a	dual	clad	catheter	(diameter:	
2.4–2.6Fr)	that	acquire	24.5–100	frames/s	and	are	pulled-back	at	a	constant	speed	by	an	automated	pull-back	device.	
Several	experimental	studies	in	animal	models	that	used	numerous	activatable	markers	have	provided	robust	evidence	
about	 the	 feasibility	 of	 combined	 OCT-NIRF	 imaging	 and	 showed	 that	 NIRF	 enables	 detection	 of	 macrophages	
accumulation	and	fibrin	deposition28,29;	but	none	of	these	markers	have	been	used	in	the	clinical	setting	yet.	
	
In	 a	 recent	 report,	 Wang	 et	 al.	 showed	 that	 necrotic-rich	 plaques	 have	 the	 ability	 to	 fluoresce	 (near	 infrared	
autofluoresnce	imaging–NIRAF)	when	they	are	excited	with	NIRF	light	at	633	nm.30	The	safety	and	the	efficacy	of	OCT-
NIRAF	 in	the	characterization	of	atherosclerosis	was	been	tested	 in	a	small	study	 involving	12	patients	undergoing	
PCI.31	The	acquired	NIRAF	emission	intensities	were	co-registered	offline	with	the	OCT	imaging	data.	A	strong	NIRAF	
signal	 was	 seen	 in	 regions	 of	 plaque	 with	 high-risk	 features	 such	 as	 lipid	 containing	 plaques,	 thin-fibrous	 caps,	
macrophages	and	ruptured	plaques	with	overlaying	thrombus.	The	authors	observed	that	not	all	 the	plaques	with	
high-risk	 features	 (i.e.	 macrophages,	 lipid-rich	 lesions)	 had	 increasedNIRAF	 signal	 and	 speculated	 that	 an	
increasedNIRAF	 signal	 may	 be	 a	 new	 imaging	 marker	 associated	 with	 increased	 plaque	 vulnerability	 (Figure	 4).	
Histological	evidence	has	showed	that	NIRAF	may	allow	detection	of	inflamed	plaques	with	oxidized	lipid	component	
and	 neo-vessels32;	 further	 research	 is	 required	 towards	 this	 direction	 in	 order	 to	 better	 understand	 the	
pathobiological	implications	and	clinical	relevance	of	an	increased	NIRAF	signal.	
	
	
Discussion–Conclusions	
	
The	first	multimodality	imaging	studies	of	coronary	atherosclerosis	have	provided	robust	evidence	that	multimodality	
intravascular	imaging	is	feasible	and	enables	more	detailed	evaluation	of	the	composition	of	the	plaque,	more	accurate	
characterization	of	 its	phenotype	and	assessment	of	plaque	features	associated	with	increased	vulnerability.	More	
importantly	 these	 studies	 eradicated	 false	 beliefs	 about	 the	 morphology	 of	 vulnerable	 plaques,	 furthered	 our	
understanding	of	plaque	vulnerability	and	demonstrated	 that	a	complete	assessment	of	plaque	pathobiology	may	
enable	more	accurate	identification	of	the	lesions	that	will	progress,	rupture	and	cause	cardiovascular	events.	Finally,	
serial	 multimodality	 imaging	 studies	 have	 allowed	 us	 to	 better	 understand	 atherosclerotic	 evolution	 and	 have	 a	
complete	assessment	of	the	effect	of	treatments	on	plaque	burden,	morphology,	and	vulnerability.	
	
However,	 although	 it	 is	 apparent	 that	 multimodality	 intravascular	 imaging	 is	 superior	 to	 standalone	 imaging	 its	
applications	 in	 the	 study	 of	 atherosclerosis	 is	 limited.	 This	 is	 attributed	 to	 the	 risk–despite	 being	 minimal–of	
complications,	 to	 the	 increased	 cost	 and	 time	 required	 for	 multimodality	 intracoronary	 imaging	 of	 the	 coronary	
arteries,	as	well	as	 the	fact	 that	co-registration	and	analysis	of	 the	acquired	data	 is	a	 tedious	and	time	consuming	
process.	Some	of	these	limitations	are	expected	to	be	overcome	by	hybrid	dual-probe	catheters,	whilst	others	such	as	
the	increased	cost,	the	partial	sampling	of	the	coronary	tree	and	the	risk	of	complications	will	remain	considerable	
pitfalls	for	intravascular	imaging.	
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Today	several	ongoing	large	scale	prospective	hybrid-invasive	imaging-based	studies	of	coronary	atherosclerosis	have	
commenced	and	are	expected	 to	provide	us	with	more	 information	on	 the	potential	 value	of	hybrid	 intravascular	
imaging	in	understanding	the	mechanisms	involved	in	atherosclerotic	plaque	development	and	destabilization	and	in	
detecting	 lesions	 that	 are	 prone	 to	 progress	 and	 cause	 events.	 The	 advent	 of	 new	 hybrid	 imaging	 modalities	 is	
anticipated	to	provide	further	opportunities	to	study	plaque	pathobiology	and	allow	reliable	detection	of	vulnerable	
plaques	 and	 patients	 that	 are	 at	 high	 risk	 to	 sustain	 future	 cardiovascular	 events.	 Preliminary	 uni-modality	
intravascular	imaging	studies	have	provided	proof	of	the	latter	concept33	and	showed	that	a	complete	assessment	of	
coronary	morphology	is	likely	to	enable	more	accurate	risk	stratification	which	would	justify	the	implementation	of	
individualized	 secondary	 prevention	 strategies	 using	 aggressive	 pharmacological	 or	 interventional	 treatments	
targeting	atherosclerotic	process	in	selected	populations.	
	
	
Conflict	of	interest:	None	declared.	
	
	
References	
1.	Bourantas	CV,	Jaffer	FA,	Gijsen	FJ,	van	Soest	G,	Madden	SP,	Courtney	BK	et	al.	Hybrid	intravascular	imaging:	recent	
advances,	technical	considerations,	and	current	applications	in	the	study	of	plaque	pathophysiology.	Eur	Heart	J	
2017;38:	400–12.	
2.	Sawada	T,	Shite	J,	Garcia-Garcia	HM,	Shinke	T,	Watanabe	S,	Otake	H	et	al.	Feasibility	of	combined	use	of	intravascular	
ultrasound	radiofrequency	data	analysis	and	optical	coherence	tomography	for	detecting	thin-cap	fibroatheroma.	
Eur	Heart	J	2008;29:1136–46.	
3.	 Fujii	 K,	 Hao	 H,	 Shibuya	 M,	 Imanaka	 T,	 Fukunaga	 M,	 Miki	 K	 et	 al.	 Accuracy	 of	 OCT,	 grayscale	 IVUS,	 and	 their	
combination	for	the	diagnosis	of	coronary	TCFA:	an	ex	vivo	validation	study.	JACC	Cardiovasc	Imaging	2015;8:451–
60.	
4.	 Brown	AJ,	Obaid	DR,	Costopoulos	C,	 Parker	RA,	 Calvert	 PA,	 Teng	 Z	 et	 al.	Direct	 comparison	of	 virtual-histology	
intravascular	ultrasound	and	optical	coherence	tomography	imaging	for	identification	of	thin-cap	fibroatheroma.	
Circ	Cardiovasc	Imaging	2015;8:e003487.	
5.	Gonzalo	N,	Garcia-Garcia	HM,	Regar	E,	Barlis	P,	Wentzel	J,	Onuma	Y	et	al.	In	vivo	assessment	of	high-risk	coronary	
plaques	 at	 bifurcations	 with	 combined	 intravascular	 ultrasound	 and	 optical	 coherence	 tomography.	 JACC	
Cardiovasc	Imaging	2009;2:473–82.	
6.	Diletti	R,	Garcia-Garcia	HM,	Gomez-Lara	J,	Brugaletta	S,	Wykrzykowska	JJ,	van	Ditzhuijzen	N	et	al.	Assessment	of	
coronary	atherosclerosis	progression	and	regression	at	bifurcations	using	combined	IVUS	and	OCT.	JACC	Cardiovasc	
Imaging	2011;4:774–80.	
7.	 Kubo	 T,	 Maehara	 A,	 Mintz	 GS,	 Doi	 H,	 Tsujita	 K,	 Choi	 SY	 et	 al.	 The	 dynamic	 nature	 of	 coronary	 artery	 lesion	
morphology	assessed	by	serial	virtual	histology	intravascular	ultrasound	tissue	characterization.	J	Am	Coll	Cardiol	
2010;55:1590–7.	
8.	Tian	J,	Ren	X,	Vergallo	R,	Xing	L,	Yu	H,	Jia	H	et	al.	Distinct	morphological	features	of	ruptured	culprit	plaque	for	acute	
coronary	events	compared	to	those	with	silent	rupture	and	thin-cap	fibroatheroma:	a	combined	optical	coherence	
tomography	and	intravascular	ultrasound	study.	J	Am	Coll	Cardiol	2014;63:2209–16.	
9.	 Ambrose	 JA,	 Tannenbaum	 MA,	 Alexopoulos	 D,	 Hjemdahl-Monsen	 CE,	 Leavy	 J,	 Weiss	 M	 et	 al.	 Angiographic	
progression	of	coronary	artery	disease	and	the	development	of	myocardial	infarction.	J	Am	Coll	Cardiol	1988;12:56–
62.	
10.	Tian	J,	Dauerman	H,	Toma	C,	Samady	H,	Itoh	T,	Kuramitsu	S	et	al.	Prevalence	and	characteristics	of	TCFA	and	degree	
of	coronary	artery	stenosis:	an	OCT,	IVUS,	and	angiographic	study.	J	Am	Coll	Cardiol	2014;64:672–80.	
	 8	
11.	Kwon	JE,	Lee	WS,	Mintz	GS,	Hong	YJ,	Lee	SY,	Kim	KS	et	al.	Multimodality	intravascular	imaging	assessment	of	plaque	
erosion	versus	plaque	rupture	in	patients	with	acute	coronary	syndrome.	Korean	Circ	J	2016;46:499–506.	
12.	Taniwaki	M,	Radu	MD,	Garcia-Garcia	HM,	Heg	D,	Kelbaek	H,	Holmvang	L	et	al.	Long-term	safety	and	feasibility	of	
three-vessel	multimodality	 intravascular	 imaging	 in	 patients	with	 ST-elevation	myocardial	 infarction:	 the	 IBIS-4	
(integrated	biomarker	and	imaging	study)	substudy.	Int	J	Cardiovasc	Imaging	2015;31:915–26.	
13.	Raber	 L,	 Taniwaki	M,	Zaugg	S,	Kelbaek	H,	Roffi	M,	Holmvang	L	et	al.	 Effect	of	high-intensity	 statin	 therapy	on	
atherosclerosis	in	non-infarct-related	coronary	arteries	(IBIS-4):	a	serial	intravascular	ultrasonography	study.	Eur	
Heart	J	2015;36:490–500.	
14.	 Brugaletta	 S,	 Garcia-Garcia	 HM,	 Serruys	 PW,	 de	 Boer	 S,	 Ligthart	 J,	 Gomez-Lara	 J	 et	 al.	 NIRS	 and	 IVUS	 for	
characterization	 of	 atherosclerosis	 in	 patients	 undergoing	 coronary	 angiography.	 JACC	 Cardiovasc	 Imaging	
2011;4:647–55.	
15.	Pu	J,	Mintz	GS,	Brilakis	ES,	Banerjee	S,	Abdel-Karim	AR,	Maini	B	et	al.	In	vivo	characterization	of	coronary	plaques:	
novel	 findings	 from	 comparing	 greyscale	 and	 virtual	 histology	 intravascular	 ultrasound	 and	 near-infrared	
spectroscopy.	Eur	Heart	J	2012;33:372–83.	
16.	Yonetsu	T,	Suh	W,	Abtahian	F,	Kato	K,	Vergallo	R,	Kim	SJ	et	al.	Comparison	of	near-infrared	spectroscopy	and	optical	
coherence	tomography	for	detection	of	lipid.	Catheter	Cardiovasc	Interv	2014;84:710–7.	
17.	Kang	SJ,	Mintz	GS,	Pu	J,	Sum	ST,	Madden	SP,	Burke	AP	et	al.	Combined	IVUS	and	NIRS	detection	of	fibroatheromas:	
histopathological	validation	in	human	coronary	arteries.	JACC	Cardiovasc	Imaging	2015;8:184–94.	
18.	 Puri	 R,	 Madder	 RD,	 Madden	 SP,	 Sum	 ST,	 Wolski	 K,	 Muller	 JE	 et	 al.	 Near-infrared	 spectroscopy	 enhances	
intravascular	ultrasound	assessment	of	vulnerable	coronary	plaque:	a	combined	pathological	and	 in	vivo	study.	
Arterioscler	Thromb	Vasc	Biol	2015;35:2423–31.	
19.	Kini	AS,	Baber	U,	Kovacic	JC,	Limaye	A,	Ali	ZA,	Sweeny	J	et	al.	Changes	 in	plaque	 lipid	content	after	short-term	
intensive	versus	standard	statin	therapy:	the	YELLOW	trial	(reduction	in	yellow	plaque	by	aggressive	lipid-lowering	
therapy).	J	Am	Coll	Cardiol	2013;62:21–9.	
20.	Bourantas	CV,	Serruys	PW.	Hybrid	 intravascular	 imaging:	 the	key	 for	a	holistic	evaluation	of	plaque	pathology.	
EuroIntervention	2014;10:296–8.	
21.	Oemrawsingh	RM,	Garcia-Garcia	HM,	van	Geuns	RJ,	Lenzen	MJ,	Simsek	C,	de	Boer	SP	et	al.	Integrated	Biomarker	
and	Imaging	Study	3	(IBIS-3)	to	assess	the	ability	of	rosuvastatin	to	decrease	necrotic	core	 in	coronary	arteries.	
EuroIntervention	2016;12:734–9.	
22.	 Roleder	 T,	 Kovacic	 JC,	 Ali	 Z,	 Sharma	 R,	 Cristea	 E,	Moreno	 P	 et	 al.	 Combined	 NIRS	 and	 IVUS	 imaging	 detects	
vulnerable	 plaque	 using	 a	 single	 catheter	 system:	 a	 head-to-head	 comparison	 with	 OCT.	 EuroIntervention	
2014;10:303–11.	
23.	Madder	RD,	Goldstein	JA,	Madden	SP,	Puri	R,	Wolski	K,	Hendricks	M	et	al.	Detection	by	near-infrared	spectroscopy	
of	large	lipid	core	plaques	at	culprit	sites	in	patients	with	acute	ST-segment	elevation	myocardial	infarction.	JACC	
Cardiovasc	Interv	2013;6:838–46.	
24.	Madder	RD,	Puri	R,	Muller	JE,	Harnek	J,	Gotberg	M,	VanOosterhout	S	et	al.	Confirmation	of	the	intracoronary	near-
infrared	 spectroscopy	 threshold	 of	 lipid-rich	 plaques	 that	 underlie	 ST-segment-elevation	myocardial	 infarction.	
Arterioscler	Thromb	Vasc	Biol	2016;36:1010–5.	
25.	 Madder	 RD,	 Husaini	 M,	 Davis	 AT,	 Van	 Oosterhout	 S,	 Harnek	 J,	 Gotberg	 M	 et	 al.	 Detection	 by	 near-infrared	
spectroscopy	of	large	lipid	cores	at	culprit	sites	in	patients	with	non-st-segment	elevation	myocardial	infarction	and	
unstable	angina.	Catheter	Cardiovasc	Interv	2015;	Nov	15;86:1014–21.	
26.	Bharadwaj	AS,	Vengrenyuk	Y,	Yoshimura	T,	Baber	U,	Hasan	C,	Narula	J	et	al.	Multimodality	Intravascular	Imaging	
to	Evaluate	Sex	Differences	in	Plaque	Morphology	in	Stable	CAD.	JACC	Cardiovasc	Imaging	2016;9:400–7.	
27.	Deguchi	JO,	Aikawa	M,	Tung	CH,	Aikawa	E,	Kim	DE,	Ntziachristos	V	et	al.	Inflammation	in	atherosclerosis:	visualizing	
matrix	metalloproteinase	action	in	macrophages	in	vivo.	Circulation	2006;114:55–62.	
	 9	
28.	Kim	S,	Lee	MW,	Kim	TS,	Song	JW,	Nam	HS,	Cho	HS	et	al.	Intracoronary	dual-modal	optical	coherence	tomography-
near-infrared	 fluorescence	 structural-molecular	 imaging	 with	 a	 clinical	 dose	 of	 indocyanine	 green	 for	 the	
assessment	
of	high-risk	plaques	and	stent-associated	inflammation	in	a	beating	coronary	artery.	Eur	Heart	J	2016;37:2833–2844.	
29.	Hara	T,	Ughi	GJ,	McCarthy	JR,	Erdem	SS,	Mauskapf	A,	Lyon	SC	et	al.	Intravascular	fibrin	molecular	imaging	improves	
the	detection	of	unhealed	stents	assessed	by	optical	coherence	tomography	in	vivo.	Eur	Heart	J	2017;38:447–55.	
30.	Wang	H,	Gardecki	 JA,	Ughi	GJ,	 Jacques	PV,	Hamidi	 E,	 Tearney	GJ.	 Ex	 vivo	 catheter-based	 imaging	of	 coronary	
atherosclerosis	using	multimodality	OCT	and	NIRAF	excited	at	633	nm.	Biomed	Opt	Exp	2015;6:1363–75.	
31.	 Ughi	 GJ,	 Wang	 H,	 Gerbaud	 E,	 Gardecki	 JA,	 Fard	 AM,	 Hamidi	 E	 et	 al.	 Clinical	 characterization	 of	 coronary	
atherosclerosis	 with	 dual-modality	 OCT	 and	 near-infrared	 autofluorescence	 imaging.	 JACC	 Cardiovasc	 Imaging	
2016;9:1304–1314.	
32.	Haka	AS,	Kramer	JR,	Dasari	RR,	Fitzmaurice	M.	Mechanism	of	ceroid	formation	in	atherosclerotic	plaque:	in	situ	
studies	using	a	combination	of	Raman	and	fluorescence	spectroscopy.	J	Biomed	Opt	2011;16:011011.	
33.	Bourantas	CV,	Garcia-Garcia	HM,	Torii	R,	Zhang	YJ,	Westwood	M,	Crake	T	et	al.	Vulnerable	plaque	detection:	an	
unrealistic	quest	or	a	feasible	objective	with	a	clinical	value?	Heart	2016;102:581–9.	
	
	
	 10	
	
	
	
	
	
	
	
	
	
	
Figure	1	Combined	OCT–virtual	histology	IVUS	(IVUS-VH)	imaging	for	more	reliable	assessment	of	plaque	morphology	
and	burden.	Corresponding	OCT	 (A),	grayscale	 IVUS	 (B),	and	 IVUS-VH	(C)	 images–the	*	 indicates	 the	origin	of	side	
branch.	Calcific	tissue	 is	detected	by	both	OCT	and	IVUS-VH	images	at	11	o’	clock	(magnified	views).	Co-registered	
OCT–grayscale	IVUS	(D)	and	OCT	–IVUS-VH	(E)	images.	OCT	confirms	the	necrotic	core	tissue	detected	in	IVUS-VH	at	2	
o’	clock,	but	not	the	necrotic	core	tissue	behind	the	calcific	plaque	at	11	o’	clock	which	appears	to	be	a	false	estimation	
and	is	due	to	artefact.	Panel	F	portrays	the	final	plaque	morphology	derived	by	the	combined	information	provided	by	
OCT	and	IVUS-VH.	
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Figure	2	Receiving	operator	characteristics	(ROC)	curve	analysis	of	the	IVUS	and	OCT	plaque	characteristics	associated	
with	plaque	rupture	(A)	and	with	plaques	that	ruptured	and	cause	a	cardiovascular	event.	Table	1	and	Table	2	provides	
the	cut-off,	the	Youden	index,	the	sensitivity,	specificity,	the	positive	and	the	negative	predictive	value	of	the	plaque	
characteristics	that	differentiate	ruptured	from	non-ruptured	TCFA	and	of	the	variables	that	differentiate	the	culprit	
from	the	non-culprit	ruptured	TCFA,	respectively.	Images	were	obtained	and	modified	with	permission	from	Tian	et	
al.8	
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Figure	 3	 Output	 of	 different	 hybrid	 intravascular	 imaging	 catheters.	 Co-registered	 IVUS	 (A)	 and	 OCT	 images	 (B)	
produced	by	 an	 IVUS-OCT	 catheter,	 showing	a	 stented	 vessel	with	 thrombus	 (indicated	with	 an	*).	Output	of	 the	
combined	OCT-NIRS	catheter	(C,	D):	the	plaque	detected	on	OCT	images	at	6	o’	clock	in	panel	(C)	does	not	correspond	
to	lipid	tissue–as	it	is	shown	by	NIRS–and	it	has	been	classified	as	fibrocalcific	while	in	panel	(D)	a	plaque	with	same	
morphological	characteristics	has	significant	NIRS	absorption	and	thus	it	has	been	classified	as	lipid-rich	plaque.	IVUS	
photoacoustic	image	(E)	produced	by	a	hybrid	IVUS-photoacoustic	catheter	and	corresponding	histological	section	(Oil	
Red	O	stained,	F).	Photoacoustic	imaging	at	1710nm	wavelength	enables	identification	of	the	lipid	tissue,	detected	
between	10	and	3	o’	clock	in	histological	section,	and	is	shown	with	red-orange	colour	in	grayscale	IVUS.	Co-registered	
IVUS-fluorescence	lifetime	imaging	(FLIm)	using	a	hybrid	IVUS-FLIm	catheter	(G).	FLIm	at	390/40nm	wavelength	band	
enables	detection	of	calcific,	collagen	and	lipid	tissue/macrophages	(H).	IVUS-FLIm	cross-sectional	images	(H1)	with	
corresponding	histological	sections	stained	with	CD68	(2)	and	elastin-Masson’s	Thichrome	(3).	IVUS-FLIm	appears	able	
to	accurately	identify	collagen	rich	tissue	(indicated	with	red	arrow,	high	lifetime	values)	and	a	thin-cap	fibroatheroma	
(yellow	arrow,	low	lifetime	values)	with	macrophages	(CD68ﬂ).	Scale	bars	1mm.	(J)	NIRF	and	IVUS	imaging	of	a	rabbit	
aorta	8	weeks	and	12	weeks	after	mechanical	injury	with	a	balloon.	A	ProSenseVM110,	a	molecular	sensor	injected	24	
h	before	 imaging	was	used	to	detect	for	cathepsin	protease	activity.	Atheroma	was	 induced	 in	the	rabbit	aorta	by	
mechanical	balloon	injury	and	hypercholesterolaemic	diet.	(K)	Cross-sectional	OCT-NIRF	image	(yellow/white	indicates	
high	and	blue/black	low	NIRF	signal)	at	the	location	of	the	white	dotted	line	in	(J).	Matched	fluorescence	microscopy	
(red	 corresponds	 to	 ProSense	 VM110;	 green	 to	 autofluorescence)	 and	 histological	 cross	 sections	 demonstrates	
increased	ProSense	VM110	NIRF	signal	in	a	fibrofatty	plaque	(H&E	staining)	associated	with	cathepsin	B	immunostain.	
Scale	bars,	1mm.	Images	obtained	with	permission	by	Bourantas	et	al.1	
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Figure	 4	 (A)	 Angiographic	 image	 showing	 a	 left	 anterior	 descending	 artery	 assessed	 by	 OCT-NIRAF	 imaging	 (ps,	
indicates	the	studied	segment).	(B)	Spread	out	plot	of	the	NIRAF	signal;	increased	signal	is	noted	in	the	distal	left	main	
stem–proximal	left	anterior	descending	artery.	OCT-NIRAF	cross-sections	in	this	segment	shows	a	lipid-rich	plaque	(C–
E)	with	a	cholesterol	crystal	(F),	and	evidence	of	plaque	rupture	(G,	H)	with	superimposed	thrombus	(I).	Longitudinal	
reconstruction	of	the	studied	segments	from	the	OCT-NIRAF	data	shows	several	lipid	rich	plaques,	while	increased	
NIRAF	activity	(indicated	with	an	arrow)	was	restricted	only	in	the	area	with	a	large	lipid	pool	and	evidence	of	plaque	
rupture.	Scale	bar	in	(B)	is	5mm	while	in	OCT	images	and	magnified	views	is	1mm	and	0.5mm,	respectively.	(*)	indicates	
the	guidewire	shadow,	(L)	lipid	tissue,	(R)	plaque	rupture,	(T)	thrombus	and	(TCFA)	thin	cap	fibroatheroma.	Image	was	
obtained	with	permission	from	Ughi	et	al.31	 	
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The	unmet	need	to	assess	plaque	pathophysiology	–	limitations	of	existing	imaging	modalities	
	
Intravascular	ultrasound	
IVUS	is	currently	the	most	widely	used	intravascular	imaging	modality.	It	provides	cross	sectional	images	of	the	vessel	
which	 allow	 identification	 of	 the	 luminal	 and	 media-adventitia	 borders,	 evaluation	 of	 the	 plaque	 burden	 and	
characterization	of	its	composition1-2.	This	modality	has	been	extensively	used	to	study	atherosclerotic	evolution	and	
the	effect	of	new	therapies	on	plaque	progression3.	Developments	in	signal	processing	have	led	to	the	development	
of	three	methods	for	the	radiofrequency	analysis	of	the	backscattered	IVUS	signal	(RF-IVUS),	namely	virtual	histology	
IVUS	 (VH-IVUS),	 iMAP-IVUS	 and	 integrated	 backscatter	 analysis4.	 These	 techniques	 have	 enabled	 more	 reliable	
characterization	of	plaque	composition	and	assessment	of	its	phenotype5.	However,	in	contrast	to	what	it	has	shown	
in	 preliminary	 histology	 and	 small	 scale	 clinical	 studies,6	 prospective	 large	 scale	 studies	 of	 atherosclerosis	
demonstrated	that	RF-IVUS	has	a	low	accuracy	in	the	prediction	of	lesions	that	are	likely	to	progress	and	cause	future	
cardiovascular	events7-8.	The	limited	accuracy	of	RF-IVUS	was	attributed	to	its	moderate	radial	imaging	resolution	(70-
150µm),	which	does	not	allow	detection	of	micro-features	associated	with	plaque	vulnerability	 (e.g.	macrophages,	
micro-calcifications,	 neo-vascularization,	 plaque	 erosion),	 and	 to	 the	 fact	 that	 RF-IVUS	 does	 not	 provide	 accurate	
assessment	of	plaque	type	within	stented	segments	and	in	plaques	with	a	complex	pathology9-10.		
	
Optical	coherence	tomography	
OCT	was	introduced	14	years	ago	in	the	clinical	arena.	This	modality	provides	high	resolution	images	(12-18µm)	that	
permit	visualization	of	all	vessel	wall	layers	(provided	that	there	is	no	disease	in	the	intima),	and	assessment	of	micro-
features	that	cannot	be	detected	by	other	imaging	modalities,	such	as	macrophages,	neo-vessels,	micro-calcifications,	
characterisation	of	the	type	of	thrombus,	and	estimation	of	the	thickness	of	the	fibrous	cap	over	lipid-rich	plaques11.	
A	recent	study	has	shown	that	OCT	enables	detection	of	 lesions	that	are	 likely	to	progress	and	cause	events12	and	
histology	studies	have	shown	that	OCT	is	superior	to	IVUS	in	assessing	the	composition	of	the	plaque13.	However,	more	
extensive	validation	has	raised	concerns	about	the	efficacy	of	this	modality	in	assessing	plaque	morphology	and	its	
ability	 to	 discriminate	 between	 deeply	 embedded	 calcific	 and	 lipid	 tissue,	 and	 identifying	 the	 presence	 of	
macrophages14-15.	 Additional	 limitations	 include	 an	 inability	 to	 penetrate	 lipid-rich	 cores	 and	 its	 limited	 tissue	
penetration	(range	2-3mm),	which	often	prevents	optimal	atheroma	visualization.	
	
Near	infrared	spectroscopy	
NIRS	is	an	intravascular	imaging	modality	that	relies	on	the	spectral	analysis	of	the	reflected	NIR	light	emitted	by	a	
catheter	 that	 is	advanced	 in	 the	coronary	arteries.	Histology-based	studies	 suggest	 that	NIRS	 is	able	 to	accurately	
assess	 the	 plaque	 composition	 and	 detect	 lipid	 cores16.	 Recent	 advances	 in	 the	 analysis	 of	 the	 NIRS	 signal	 have	
permitted	assessment	of	the	thickness	and	composition	of	the	fibrous	cap	over	lipid-rich	plaques	and	differentiation	
of	thin	(TCFA)	from	thick	cap	fibroatheromas	(FA)17.	
	
Nevertheless,	a	more	extensive	validation	suggested	that	NIRS	may	be	superior	to	IVUS	in	the	detection	of	plaques	
with	an	increased	necrotic	core	component,	but	it	also	has	limited	accuracy	in	the	characterization	of	the	phenotype	
of	the	plaque18.	Other	significant	limitations	of	NIRS	technology	include	the	lack	of	image	depth	resolution,	the	fact	
that	 it	 does	 not	 enable	 quantification	 of	 plaque	 burden,	 visualization	 of	 the	 lumen	 and	 outer	 vessel	 wall,	 and	
assessment	 of	 plaque	 micro-characteristics	 associated	 with	 increased	 vulnerability	 such	 as	 plaque	 erosion,	 neo-
vascularization	and	microcalcification.	
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Table	1.	Multimodality	imaging	studies	examining	the	value	of	combined	intravascular	imaging	in	the	study	of	atherosclerosis.			
Study	 Aim	 Num	of	
patients	
Num	of	
studied	
segments	
Imaging	
modality	
Results	
Sawada	et	al19	 To	assess	the	efficacy	of	RF-IVUS	
and	 OCT	 in	 detecting	 TCFA	
(defined	 as	 plaques	 that	 met	
both	 the	 RF-IVUS	 and	 OCT	
criteria)	
56	 126	 RF-IVUS	and	OCT	 1.	RF-IVUS	had	only	46%	positive	ratio	in	detecting	TCFA.	Its	limited	accuracy	was	due	to	
its	moderate	 resolution	which	 did	 not	 allow	 accurate	 assessment	 of	 the	 fibrous	 cap	
thickness	
2.	OCT	had	a	higher	positive	ratio	of	78%	in	detecting	TCFA;	the	cause	of	failure	for	OCT	
was	the	erroneous	detection	of	lipid	cores	
Gonzalo	et	al20	 To	 evaluate	 the	 distribution	 of	
different	 plaque	 types	 in	
bifurcations	 using	
multimodality	imaging		
30	 103	 RF-IVUS	and	OCT	 1.	Lipid	rich	plaques	(FA,	TCFA)	were	seen	in	43.7%	of	the	studied	lesions	
2.	The	necrotic	core	percentage	was	decreasing	from	the	proximal	to	the	distal	rim	of	
the	ostium	of	the	side	branch		while	the	cap	thickness	showed	an	inverse	tendency	
3.	Lipid	rich	plaques	were	seen	more	often	in	the	proximal	rim	and	in-bifurcation	site	
than	the	distal	rim	of	the	bifurcation	
Diletti	et	al21	 To	 assess	 changes	 in	 the	
phenotype	 of	 the	 plaque	 in	
bifurcations		
24	 56	 RF-IVUS	 and	OCT	
at	baseline	and	6-
month	follow-up	
1.	Most	 of	 the	 lipid-rich	 plaques	 (81%)	 did	 not	 change	 their	 phenotype	 at	 6	months	
follow-up	
2.	No	differences	were	noted	in	the	necrotic	core	component	and	fibrous	cap	thickness	
at	follow-up	
Tian	et	al22	 To	 indentify	 morphological	
characteristics	of	asymptomatic	
TCFA,	 ruptured	 non-culprit	
plaques	 and	 ruptured	 culprit	
plaques	
82	 126	 Grayscale	 IVUS	
and	OCT	
1.	Cap	thickness	was	smaller	in	ruptured	plaques	
2.	Plaque	burden	was	 increased	and	the	 lumen	area	was	smaller	 in	ruptured	plaques	
that	cause	events	
3.	Combined	 IVUS-OCT	 imaging	enabled	prediction	of	plaques	that	will	 rupture	(OCT-
derived	cap	thickness	was	the	best	predictor	of	plaque	rupture)	and	cause	events	(IVUS-
derived	plaque	burden	was	the	best	predictor	of	ruptured	plaques	that	caused	events)	
Tian	et	al23	 To	 investigate	 the	 association	
between	 lesion	 severity	 and	
plaque	morphology	
255	 643	 Grayscale	 IVUS	
and	OCT		
1.	 TCFA	 were	 seen	 more	 often	 in	 lesions	 that	 had	 a	 significant	 (>70%)	 stenosis	 on	
angiography		
2.	Severely	(>70%)	stenotic	lesions	had	a	thinner	fibrous	cap	and	exhibited	more	often	
plaque	features	associated	with	plaque	vulnerability	(i.e.,	micro-vessels	and	cholesterol	
crystals)	
Kwon	et	al24	 Compared	 morphological	
characteristics	 in	 plaques	 that	
rupture	 and	 those	 that	 erode	
and	cause	events	
133	patients;	90	
with	 plaque	
rupture	 and	 43	
with	 plaque	
erosion		
133;	 90	 with	
plaque	
rupture	 and	
43	 with	
plaque	
erosion	
RF-IVUS	and	OCT	 1.	 IVUS	 showed	 that	 plaques	 that	 erode	 had	 lower	 plaque	 burden,	 exhibited	 often	
negative	remodelling,	and	were	rich	in	fibrotic	tissue	
2.	OCT	showed	that	plaques	that	erode	had	more	often	white	thrombus	and	in	25%	of	
the	cases	were	located	at	the	site	of	the	minimum	lumen	area,	whereas	the	ruptured	
plaques	were	seen	only	in	the	proximal	or	distal	shoulder	of	the	lesion			
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Hou	et	al25	 To	quantify	 the	 effect	 of	 statin	
therapy	on	plaque	progression		
46;	 27	 patients	
treated	 with	
60mg	 and	 19	
with	 20	 mg	
atorvastatin	
66;	 36	 in	 the	
high	 intensity	
and	 30	 in	 the	
low	 intensity	
statin	group		
Grayscale	 IVUS	
and	 OCT	 at	
baseline,	 6	 and	
12	 months	
follow-up	
Higher	dose	atorvastatin	resulted	in:	
1.	Greater	increase	in	fibrous	cap	thickness	(%	change:	139±161%	vs.	68±84%,	P=0.040)	
at	6	months	follow-up	
2.	A	increased	reduction	in	the	maximum	lipid	arc	(%	change:	-10±18	vs	3.8±31,	P=0.041)	
and	macrophages	accumulation	(%	change:	-19%	vs.	-3%)	at	6	months	follow-up	
No	difference	in	the	changes	in	plaque	between	groups	
Gin	et	al26	 To	 assess	 the	 effect	 of	 statin		
therapy	 on	 plaque	
characteristics	 in	 patients	 with	
stable	 angina	 and	 an	 acute	
coronary	syndrome		
69;	 14	 with	
stable	 angina,	
55	 with	 an	
acute	 coronary	
syndrome	
97;	 23	 in	 the	
stable	 angina	
and	 74	 in	 the	
acute	
coronary	
syndrome	
group	
Grayscale	 IVUS	
and	 OCT	 at	
baseline,	 6	
months	 and	 12	
months	follow-up	
1.	Fibrous	cap	thickness	increased	in	both	groups	at	12	months	follow-up;	 in	patients	
with	 an	 acute	 coronary	 syndrome	 this	 increase	 was	 higher	 (193	 vs.	 128,	 P=0.018)	
comparing	to	those	with	stable	angina	
2.	In	patients	with	an	acute	coronary	syndrome	reduction	of	the	microvessels	was	also	
noted	at	follow-up	(45	at	baseline	vs.	27	at	12	months	follow-up;	P=0.039)		
3.	There	were	no	differences	in	plaque	burden	between	baseline	and	follow-up	in	both	
groups	
Taniwaki	et	al27	 To	 examine	 the	 safety	 and	
feasibility	 of	 multimodality	
imaging	 in	 the	 3	 epicardial	
coronary	arteries	
103	 patients	
admitted	 with	
STEMI	
103	 culprit	
and	 204	 non-
culprit	vessels	
RF-IVUS	 and	OCT	
at	 baseline	 and	
13	 months	
follow-up	
1.	Multi-modality	serial	 intravascular	 imaging	was	 feasible	 in	 the	vast	majority	of	 the	
culprit	and	non-culprit	vessels	
2.	 Multimodality	 imaging	 was	 safe	 (complication	 rate	 1.9%	 at	 baseline	 and	 1.1%	 at	
follow-up)	
Kini	et	al28	 To	 examine	 in	 obstructive	
lesions	 the	 effect	 of	 aggressive	
lipid	 lowering	 treatment	
(rosuvastatin	 40mg	 od)	 on	
plaque	characteristics	
87;	 44	 patients	
randomized	 to	
intensive	and	to	
43	 standard	 of	
care	 lipid	
lowering	
therapy	
87;	 44	
allocated	 to	
intensive	 and	
43	 to	
standard	 lipid	
lowering	
therapy	
Grayscale	 IVUS,	
NIRS	 and	 FFR	 at	
baseline	 and	 7	
weeks	follow-up	
1.	In	contrast	to	the	standard	of	care	group,	patients	treated	with	intensive	lipid	lowering	
therapy	had	a	significant	reduction	in	the	lipid	component	at	follow-up(	change	in	the		
maxLCBI4mm	−149.1	[−210.9	to	−42.9]	vs.	2.4	[−36.1	to	44.7];	P=0.01)	
2.	There	were	no	differences	in	the	plaque	burden	and	FFR	measurements	at	baseline	
and	follow-up	in	both	groups.		
	
Oemrawshingh	
et	al29	
To	 examine	 the	 implications	 of	
aggressive	 lipid	 lowering	
treatment	 (rosuvastatin	 40mg)	
on	 the	 composition	 of	 the	
plaque	
103	 103	 NIRS	and	RF-IVUS	
imaging	 at	
baseline	and	6	or	
12	 months	
follow-up	
1.	Aggressive	lipid	lowering	therapy	had	no	effect	in	the	lipid	component	assessed	by	
either	NIRS	(LCBI:	44.9±51.1	at	baseline	vs.	46.1±43.2	at	follow-up,	P=0.80;	maxLCBI4mm:	
201.9±163.8	 at	 baseline	 vs.	 206.8±154.5	 at	 follow-up,	 P=0.72)	 or	 RF-IVUS	 imaging	
(necrotic	core	component:	29.1±31.9mm3	at	baseline	vs.		27.7±31.2mm3	at	follow-up,	
P=0.074)		
2.	An	increase	in	the	percentage	atheroma	volume	was	noted	at	follow-up(40.7±10.2%	
at	baseline	vs.	41.6±9.7%,	P=0.001)	
	
Table	footnote:	RF-IVUS,	radiofrequency	analysis	of	the	intravascular	ultrasound	data;	OCT,	optical	coherence	tomography;	TFCA,	thin	cap	fibroatheroma;	FA,	fibrotatheroma;		
NIRS,	near	infrared	spectroscopy;	FFR,	fractional	flow	reserve;	STEMI,	ST-elevation	myocardial	infarction,	maxLCBI4mm,	maximum	lipid	core	burden	index	in	4mm	segment.	
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Table	2.	Design	and	findings	of	studies	that	utilize	dual-probe	imaging	catheters.	
Study	 Aim	 Num	of	
patients	
Num	of	
studied	
segments	
Imaging	
modality	
Results	
Roleder	
et	al	30	
To	 assess	 the	 accuracy	 of	 NIRS-
IVUS	 imaging	 in	 detecting	 OCT-
defined	TCFA	
60	 76	 NIRS-IVUS	
and	OCT	
1.	OCT-defined	TCFA	had	positive	remodelling,	increased	plaque	burden	and	smaller	lumen	area	
on	IVUS	and	increased	lipid	component	in	NIRS		
2.	 Combined	 NIRS-IVUS	 imaging	 had	 a	 higher	 accuracy	 (sensitivity:	 100%,	 specificity:	 91%)	 in	
detecting	OCT-derived	TCFA	 than	 IVUS	 (sensitivity:	 100%,	 specificity:	 69%)	or	NIRS	 (sensitivity:	
100%,	specificity:	78%)	
Madder	
et	al	31	
To	 examine	 the	 value	 of	 NIRS-
IVUS	 in	 differentiating	 culprit	
from	 non-culprit	 lesions	 in	
patients	admitted	with	a	STEMI	
20	 20	 culprit	
vessels	
NIRS-IVUS	 1.	Culprit	plaques	had	an	increased	lipid	component	on	NIRS	and	plaque	burden	on	IVUS	
2.	The	lipid	burden	estimated	by	NIRS	was	the	only	independent	predictor	of	culprit	lesions	and	
had	an	high	accuracy	in	detecting	these	lesions	(AUC:	0.90)	
Madder	
et	al	32	
To	prospectively	assess	the	value	
of	NIRS-IVUS	in	detecting	culprit	
from	 non-culprit	 lesions	 in	
patients	with	a	STEMI	
75	 75	 culprit	
vessels	
NIRS-IVUS	 1.	A	maxLCBI4mm>400	was	able	to	identify	culprit	from	non-culprit	lesions	with	high	accuracy	(c-
statistic:	0.83)	
2.	 An	 increased	 plaque	 burden	 (>50%)	 and	 the	 presence	 of	 calcification	were	 able	 to	 identify	
culprit	lesions	(c-statistic:	0.81	and	0.67	respectively)	
3.	In	multivariate	analysis	maxLCBI4mm>400	and	plaque	burden	were	the	only	variables	that	were	
associated	with	culprit	lesions	
Madder	
et	al	33	
To	 assess	 using	 NIRS-IVUS	
morphological	 differences	
between	 culprit	 and	 non-culprit	
lesions	 in	 patients	 with	 non-
STEMI	and	unstable	angina	
81;	 43	 non-
STEMI	 and	 38	
unstable	 angina	
patients	
81;	43	in	non-
STEMI	and	38	
in	 unstable	
angina	
patients	
NIRS-IVUS	 1.	Compared	to	non-culprit	plaques	the	culprit	lesions	had	an	increased	lipid	burden	in	both	non-
STEMI	(3.4-fold	higher)	and	unstable	angina	patients	(2.6-fold	higher)	
2.	The	lipid	burden	estimated	by	NIRS	allowed	with	a	high	accuracy	detection	of	culprit	lesions	in	
both	groups		(AUC:	0.87	in	the	non-STEMI,	and	0.79	in	the	unstable	angina	group)	
Bharadwaj	
et	al	34	
To	 examine	 sex	 differences	 in	
plaque	 morphology	 in	 patients	
with	stable	angina	
128;	95	male,	33	
female		
128	 IVUS-NIRS	
and	OCT	
1.	There	were	no	differences	 in	plaque	morphology,	cap	thickness,	macrophages	accumulation	
and	calcific	burden	between	males	and	females	
2.	 Men	 had	 increased	 plaque	 burden	 (44.4%	 vs.	 39.3%,	 P=0.031)	 in	 the	 reference	 segment	
compared	to	women	but	not	in	the	minimum	lumen	site	
3.	 After	 adjusting	 for	 baseline	 characteristics	 sex	 was	 not	 a	 predictor	 of	 an	 increased	 plaque	
burden	at	the	reference	segment	
Ughi	
et	al35	
To	 examine	 the	 safety	 and	
feasibility	of	OCT-NIRAF	imaging	
12	 17	 OCT-NIRAF	 1.	Image	acquisition	was	successful	in	all	the	studied	segments	
2.	There	was	an	excellent	reproducibility	of	the	NIRAF	signal	in	4	segments	that	had	repeated	pull-
backs		
3.	 An	 increased	 NIRAF	 signal	 was	 noted	 in	 ruptured	 plaques	 and	 in	 lesions	 with	 a	 high-risk	
phenotype	
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